Header cover image
  • Investing Ideas
  • /
  • Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20

Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20

Results

5

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

5 companies

Huadong Medicine

Market Cap: CN¥65.8b

Engages in the wholesale and retail of pharmaceutical products in China and internationally.

000963

CN¥37.62

7D

-2.5%

1Y

14.8%

Shanghai Pharmaceuticals Holding

Market Cap: CN¥60.2b

Shanghai Pharmaceuticals Holding Co., Ltd.

601607

CN¥18.24

7D

-1.7%

1Y

2.2%

Tibet Rhodiola Pharmaceutical Holding

Market Cap: CN¥11.8b

Tibet Rhodiola Pharmaceutical Holding Co.

600211

CN¥36.51

7D

-0.9%

1Y

0.2%

HangzhouS MedTech

Market Cap: CN¥4.8b

Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China.

688581

CN¥60.11

7D

-2.5%

1Y

7.4%

Innovita Biological Technology

Market Cap: CN¥4.5b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥33.30

7D

4.0%

1Y

-9.7%